StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.97−0.08 (-3.90%)

Close on Nov 18, 2026Market cap $125.49MP/E –Yield –

MacroGenics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

MacroGenics's shares outstanding was 64M at Jun 30, 2026. For fiscal 2025 it was 63M, up 0.9% from the year before. Over ten years it grew 7.1% a year on average. The highest annual figure on record is 63M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202563M+0.9%
FY2024Dec 31, 202463M+1.1%
FY2023Dec 31, 202362M+0.8%
FY2022Dec 31, 202261M+2.5%
FY2021Dec 31, 202160M+14.3%
FY2020Dec 31, 202052M+9.1%
FY2019Dec 31, 201948M+17.5%
FY2018Dec 31, 201841M+13.4%
FY2017Dec 31, 201736M+4.1%
FY2016Dec 31, 201635M+9.1%
FY2015Dec 31, 201532M+16.1%
FY2014Dec 31, 201427M+299.9%
FY2013Dec 31, 20137M+532.1%
FY2012Dec 31, 20121M+5.6%
FY2011Dec 31, 20111M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202664M+0.7%
Q1 FY2026Mar 31, 202663M+0.8%
Q4 FY2025Dec 31, 202563M+0.8%
Q3 FY2025Sep 30, 202563M+0.7%
Q2 FY2025Jun 30, 202563M+0.8%
Q1 FY2025Mar 31, 202563M+1.1%
Q4 FY2024Dec 31, 202463M+2.2%
Q3 FY2024Sep 30, 202463M+1.0%
Q2 FY2024Jun 30, 202463M+0.6%
Q1 FY2024Mar 31, 202462M+0.8%
Q4 FY2023Dec 31, 202361M-0.2%
Q3 FY2023Sep 30, 202362M+1.3%
Q2 FY2023Jun 30, 202362M+1.4%
Q1 FY2023Mar 31, 202362M+0.8%
Q4 FY2022Dec 31, 202262M+0.4%
Q3 FY2022Sep 30, 202261M+0.5%
Q2 FY2022Jun 30, 202261M+2.2%
Q1 FY2022Mar 31, 202261M+7.2%
Q4 FY2021Dec 31, 202161M+9.0%
Q3 FY2021Sep 30, 202161M+12.3%
Q2 FY2021Jun 30, 202160M+20.1%
Q1 FY2021Mar 31, 202157M+16.7%
Q4 FY2020Dec 31, 202056M+14.9%
Q3 FY2020Sep 30, 202054M+11.4%
Q2 FY2020Jun 30, 202050M+2.4%
Q1 FY2020Mar 31, 202049M+7.5%
Q4 FY2019Dec 31, 201949M+15.7%
Q3 FY2019Sep 30, 201949M+15.8%
Q2 FY2019Jun 30, 201949M+15.9%
Q1 FY2019Mar 31, 201946M+23.5%
Q4 FY2018Dec 31, 201842M+14.9%
Q3 FY2018Sep 30, 201842M+14.8%
Q2 FY2018Jun 30, 201842M+17.8%
Q1 FY2018Mar 31, 201837M+5.7%
Q4 FY2017Dec 31, 201737M+5.7%
Q3 FY2017Sep 30, 201737M+5.8%
Q2 FY2017Jun 30, 201736M–
Q1 FY2017Mar 31, 201735M–
Q4 FY2016Dec 31, 201635M–
Q3 FY2016Sep 30, 201635M–

More MacroGenics figures

See a number that looks wrong?